Business · 23/09/1999Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 44 Abbreviated New Drug Applications
Summary
The Food and Drug Administration (FDA) has withdrawn the approval of 44 abbreviated new drug applications (ANDA's) following notification from the applicants that the corresponding drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →